The University City Science Center granted $700,000 to four life science researchers in Greater Philadelphia. This is a part of the University City Science Center’s QED Program that provides funds and support to academic researchers to transform their ideas into commercialized technologies.
“Over the last 10 years, we’ve worked with over 100 researchers developing promising technologies in an effort to bridge the divide between basic research and technology commercialization,” said Science Center President and CEO Steve Zarrilli in a statement. “Thirty-eight projects funded and 10 licensing deals later, we’re proud of the platform we’ve developed and the impact we’ve seen as a result of the program.”
The recipients of this year’s QED Program are:
- Ahad Behboodi, University of Delaware — Developing a compact and soft mechanized brace for people with ankle control deficits, to help them walk more easily and longer
- Jacob S. Brenner, University of Pennsylvania — Developing a vest that relieves shortness of breath in chronic obstructive pulmonary disease (COPD) patients
- John M. Maris, Children’s Hospital of Philadelphia — Developing a T-cell based immunotherapeutic treatment for children with neuroblastoma
- Servio H. Ramirez, Lewis Katz School of Medicine at Temple University — Advancing the development of a blood test for the evaluation of traumatic brain injury
In 2016, the University City Science Center helped generate $13 billion for the local economy. The Science Centers efforts encourage innovation and support local startups that could foster future economic growth in our region.